October 30, 2020 Comments Off on New patent for Osmotica Pharm drug OSMOLEX ER Posted in: Patent Added Annual Drug Patent Expirations for OSMOLEX+ER Osmolex Er is a drug marketed by Osmotica Pharm and is included in one NDA. It is available from one supplier. There are eight…
The post New patent for Osmotica Pharm drug OSMOLEX ER appeared first on DrugP…
October 30, 2020 Comments Off on New patent for Intercept Pharms drug OCALIVA Posted in: Patent Added Annual Drug Patent Expirations for OCALIVA Ocaliva is a drug marketed by Intercept Pharms Inc and is included in one NDA. It is available from one supplier. There are eight…
The post New patent for Intercept Pharms drug OCALIVA appeared first on DrugPa…
